[go: up one dir, main page]

PE20091027A1 - Unidades de envasado con un agentedesecante - Google Patents

Unidades de envasado con un agentedesecante

Info

Publication number
PE20091027A1
PE20091027A1 PE2008001235A PE2008001235A PE20091027A1 PE 20091027 A1 PE20091027 A1 PE 20091027A1 PE 2008001235 A PE2008001235 A PE 2008001235A PE 2008001235 A PE2008001235 A PE 2008001235A PE 20091027 A1 PE20091027 A1 PE 20091027A1
Authority
PE
Peru
Prior art keywords
humidity
atmosphere
desiccating agent
conditioning
agent
Prior art date
Application number
PE2008001235A
Other languages
English (en)
Inventor
Eduard Balthes
Johannes Geser
Burkhard P Metzger
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of PE20091027A1 publication Critical patent/PE20091027A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/02—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/062—Desiccants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0233—Conductive materials, e.g. antistatic coatings for spark prevention

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Packages (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

REFERIDO A UN PROCEDIMIENTO PARA PRETRATAR UN AGENTE DESECANTE PARA UNA UNIDAD DE ENVASADO PARA FORMULACIONES DE SUSTANCIAS ACTIVAS FARMACEUTICAS, CARACTERIZADO PORQUE, ANTES DE LA INTRODUCCION DEL AGENTE DESECANTE EN LA UNIDAD DE ENVASADO, SE EXPONE EL AGENTE DESECANTE, COMO PASO DE ACONDICIONAMIENTO ADICIONAL, A UNA ATMOSFERA CON HUMEDAD DEFINIDA QUE TIENE UNA HUMEDAD RESIDUAL DETERMINADA; EN DONDE LA DURACION PARA ESTE PASO ADICIONAL DE ACONDICIONAMIENTO SE FIJA DEPENDIENDO DE QUE SE ALCANCE UN EQUILIBRIO DE HUMEDAD ENTRE EL AGENTE DESECANTE Y LA ATMOSFERA CIRCUNDANTE. LA HUMEDAD RESIDUAL DE LA ATMOSFERA CON HUMEDAD SE AJUSTA EN FUNCION DE LA HUMEDAD RESIDUAL MINIMA DESEADA EN LA UNIDAD DE ENVASADO DESPUES DE ENVASAR LA FORMULACION DE SUSTANCIA ACTIVA FARMACEUTICA. ADICIONALMENTE, SE ESTABLECE UNA DISTRIBUCION HOMOGENEA DE LA ATMOSFERA CON HUMEDAD, SOBRE EL AGENTE DESECANTE, DURANTE EL PASO ADICIONAL DE ACONDICIONAMIENTO
PE2008001235A 2007-07-21 2008-07-18 Unidades de envasado con un agentedesecante PE20091027A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007034157 2007-07-21
DE102007036415 2007-08-02

Publications (1)

Publication Number Publication Date
PE20091027A1 true PE20091027A1 (es) 2009-08-17

Family

ID=39877985

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001235A PE20091027A1 (es) 2007-07-21 2008-07-18 Unidades de envasado con un agentedesecante

Country Status (10)

Country Link
US (1) US20110036733A1 (es)
EP (1) EP2170730A1 (es)
JP (1) JP2011509694A (es)
AR (1) AR067867A1 (es)
CA (1) CA2694043A1 (es)
CL (1) CL2008002136A1 (es)
PE (1) PE20091027A1 (es)
TW (1) TW200911218A (es)
UY (1) UY31233A1 (es)
WO (1) WO2009013243A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007036411A1 (de) * 2007-07-20 2009-02-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverinhalator
EP4403231A3 (en) 2009-02-26 2024-10-23 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
DK2277799T3 (da) * 2009-07-23 2012-05-21 Airsec Sas Hydreret fugtighedsbekæmpelsesstof og fremgangsmåde til fremstilling deraf
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
EP3461474B1 (en) 2010-08-31 2020-11-11 GlaxoSmithKline Intellectual Property Development Limited Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
US10350540B2 (en) 2015-05-26 2019-07-16 Donaldson Company, Inc. Adsorbent assembly with customizable humidity for an enclosure

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4997082A (en) * 1988-06-28 1991-03-05 Kimberly-Clark Corporation Humidistat
JP2705302B2 (ja) * 1990-01-19 1998-01-28 日本電気株式会社 磁気ディスク装置
DE9013901U1 (de) * 1990-10-05 1990-12-20 Hoechst Ag, 6230 Frankfurt Arzneimittelverpackung mit Kappenverschluß
US8110260B2 (en) * 2007-02-02 2012-02-07 Rick Merical Containers intended for moisture-sensitive products
JP2005015568A (ja) * 2003-06-24 2005-01-20 Fujimori Kogyo Co Ltd 吸湿性組成物、吸湿性成形体及び吸湿性積層体
JP4248986B2 (ja) * 2003-10-01 2009-04-02 凸版印刷株式会社 酸素吸収性積層体、これを用いた包装体およびこれを用いた内容物の充填方法
JP2005272009A (ja) * 2004-02-23 2005-10-06 Toppan Printing Co Ltd 多層包装体
JP2006044772A (ja) * 2004-08-06 2006-02-16 Toppan Printing Co Ltd 複合キャップおよびその複合キャップを備えた容器
US20060144726A1 (en) * 2004-12-30 2006-07-06 Foust Kevin D Container assembly
US20060144733A1 (en) * 2004-12-30 2006-07-06 3M Innovative Properties Company Container assembly and method for humidity control
JP2006286734A (ja) * 2005-03-31 2006-10-19 Nippon Chemicon Corp 固体電解コンデンサ
US7571687B2 (en) * 2006-08-08 2009-08-11 Cornellier J Rene Apparatus for destruction of organic pollutants

Also Published As

Publication number Publication date
CL2008002136A1 (es) 2009-12-11
UY31233A1 (es) 2009-03-02
WO2009013243A1 (de) 2009-01-29
TW200911218A (en) 2009-03-16
EP2170730A1 (de) 2010-04-07
WO2009013243A9 (de) 2009-03-26
JP2011509694A (ja) 2011-03-31
AR067867A1 (es) 2009-10-28
US20110036733A1 (en) 2011-02-17
CA2694043A1 (en) 2009-01-29

Similar Documents

Publication Publication Date Title
PE20091027A1 (es) Unidades de envasado con un agentedesecante
CR20120140A (es) Composiciones de liberación controlada
CL2015001984A1 (es) (divisional de la sol. 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos.
CR11167A (es) Uso de homo y copolimeros para la estabilizacion de formulaciones de principios activos
BR112016002646A2 (pt) dispositivos e métodos de entrega de fármaco de múltiplas unidades
EP2917180A4 (en) GPR40 RECEPTOR AGONIST, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREFORE AS AN ACTIVE SUBSTANCE
CO7151487A2 (es) Formulación de anticuerpos
CO6660512A2 (es) Proceso para fabricar composiciones hemostáticas secas y estables
EA201290381A1 (ru) Применение содержащего тритерпены олеогеля для заживления ран
BRPI0707612B8 (pt) vaso lacrado e formulações líquidas contidas no mesmo
EA201892595A1 (ru) Назальные фармацевтические композиции с пористым наполнителем
MX2020006664A (es) Composiciones liquidas de suministro.
CL2008002720A1 (es) Composicion farmaceutica transdermica para nebulizar, sin alcohol, que comprende uno o mas farmacos, los potenciadores de la penetracion transdermica eteres de dietilenglicol o filtros solares de ester, y liquidos no volatiles; dispositivo de dosificacion de nebulizacion medida que la comprende; metodo de fabricacion; y su uso.
MX2017016649A (es) Aparato energizado para modificacion ambiental que comprende mezclas de perfume que tienen un indice olfativo.
AR059350A1 (es) Formulacion farmaceutica para aerosoles con dos o mas principios activos y al menos una sustancia tensioactiva
BR112018006584A2 (pt) dispositivo emanador de perfume
AR082155A1 (es) Formulacion antiseptica y desinfectante que tiene contenido de yodo reducido
GT201700280A (es) Formulación sólida oral que contiene irinotecán y método de preparación de la misma
MX2020008323A (es) Composiciones farmacéuticas hipertónicas que contienen un agente quimioprotector antiplatino.
AR055838A1 (es) Formulaciones para microproyecciones recubiertas que tienen solubilidad controlada
PE20160850A1 (es) Sistema multiparticulado para administrar drogas
CO6410307A2 (es) Formulación de doramectina en dosis elevada
BR112014003790A2 (pt) ambientador de ar de carragenina em gel
BR112015000647A2 (pt) composições orais líquidas e pediátricas que contêm nepadutant
FI3790529T3 (fi) Formulaatiot, jotka käsittävät aktiivista happea ja laitteita niiden käyttämiseksi

Legal Events

Date Code Title Description
FD Application declared void or lapsed